Dark

Check out our API

AQSZF
AEQUUS PHARMACEUTICAL INC
stock OTC

EOD

Sep 30, 2026

0.000700USD0.000%(0.000000)3,815

Pre-market

0.00USD-100.000%(0.00)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Jan 24, 2022

08:00AM EST Aequus Extends Commercial Agreement for Specialty Product GlobeNewswire Inc

Jan 11, 2022

09:00AM EST Sandoz and Aequus Agree to 1-Year Extension on Vistitan in Canada GlobeNewswire Inc

Jan 6, 2022

09:00AM EST Health Canada Submission of Preservative-Free Prescription Zimed PF Accepted for Screening GlobeNewswire Inc

Nov 3, 2021

05:00AM EDT Aequus Reports Third Quarter 2021 Financial Highlights GlobeNewswire Inc

Aug 30, 2021

08:00AM EDT Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (Aequus or the Company), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, today reported financial results for the quarter ended June 30, 2021 (Second Quarter 2021) and associated Company developments. Unless otherwise noted, all figures are in Canadian currency. GlobeNewswire Inc

Aug 25, 2021

08:00AM EDT Aequus Strengthens Clinical Experience in Stargardt Disease with GlobeNewswire Inc

Aug 17, 2021

08:02AM EDT Aequus and reVision to Collaborate on Stargardt Disease Program PR Newswire

Jun 9, 2021

08:00AM EDT Aequus Provides Commercial Update GlobeNewswire Inc

May 31, 2021

05:00AM EDT Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (Aequus or the Company), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, today reported financial results for the quarter ended March 31, 2021 (First Quarter 2021) and associated Company developments. Unless otherwise noted, all figures are in Canadian currency. GlobeNewswire Inc

Apr 23, 2021

05:00AM EDT Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (Aequus or the Company), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, today reported financial results for the year ended December 31, 2020 (Fiscal 2020) and associated Company developments. Unless otherwise noted, all figures are in Canadian currency. GlobeNewswire Inc

Apr 19, 2021

08:00AM EDT Aequus Pharmaceuticals Inc. (TSX: AQS, OTCQB: AQSZF), a Canadian based specialty pharmaceutical company, will be presenting at the 2021 Bloom Burton & Co. Healthcare Investor Conference. Chairman and CEO, Doug Janzen, is scheduled to present at the conference on: GlobeNewswire Inc

Mar 1, 2021

08:00AM EST Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (Aequus or the Company), a Canadian specialty pharmaceutical company announces the commercial availability of EvolveTM preservative free lubricating eye drops for dry eye care. GlobeNewswire Inc

Dec 23, 2020

04:32PM EST Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, announced today a message from the CEO and Chairman of Aequus, Doug Janzen. GlobeNewswire Inc

Nov 30, 2020

09:00AM EST Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (Aequus or the Company), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, today reported financial results for the three months ended September 30, 2020 (Q3 2020) and associated Company developments. Unless otherwise noted, all figures are in Canadian currency. GlobeNewswire Inc

Oct 29, 2020

08:00AM EDT Aequus Receives Approval for New Evolve - Daily GlobeNewswire Inc

Oct 19, 2020

08:00AM EDT Aequus Receives Approval for New Evolve - GlobeNewswire Inc

Oct 16, 2020

08:00AM EDT Aequus Extends Commercial Agreement for Specialty Product GlobeNewswire Inc

Sep 22, 2020

09:37AM EDT Aequus Announces Expansion of Medicom Partnership and Filing with GlobeNewswire Inc

Sep 14, 2020

12:51PM EDT Aequus Announces Filing of New Medical Device License for Evolve GlobeNewswire Inc

Aug 31, 2020

08:30AM EDT Aequus Prepares for Health Canada Regulatory Filing as Partner GlobeNewswire Inc

Aug 27, 2020

09:30PM EDT Aequus Provides General Update and Second Quarter 2020 Financial GlobeNewswire Inc

Aug 26, 2020

08:15AM EDT Aequus Announces Issuance of Stock Options GlobeNewswire Inc

Aug 20, 2020

08:30AM EDT Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (Aequus or the Company), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, is pleased to welcome Grant Larsen to the Aequus Team as Chief Commercial Officer, beginning August 17th, 2020. GlobeNewswire Inc

Share